We are live on ! Find out more
JP

Jana Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 4.95%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+4.95%
3 Year Est. Return
+36.05%
5 Year Est. Return
+49.5%
10 Year Est. Return
+209.08%
AUM
$5.71B
AUM Growth
-$140M
Cap. Flow
-$332M
Cap. Flow %
-5.82%
Top 10 Hldgs %
64.77%
Holding
67
New
30
Increased
7
Reduced
8
Closed
18

Sector Composition

1 Consumer Staples 20.92%
2 Communication Services 13.65%
3 Industrials 13.11%
4 Consumer Discretionary 5.99%
5 Technology 5.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MON
26
DELISTED
Monsanto Co
MON
$20.4M 0.36%
+200,000
New +$21M
KATE
27
DELISTED
Kate Spade & Company
KATE
$18.3M 0.32%
+1,066,833
New +$20.7M
XLE icon
28
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$10.1M 0.18%
+286,000
New +$9.8M
XLF icon
29
CALL
State Street Financial Select Sector SPDR ETF
XLF
$55.3B
$9.65M 0.17%
500,000
-639,146
-56% -$13.2M
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$776B
$9.41M 0.16%
+43,500
New +$9.4M
YHOO
31
DELISTED
Yahoo Inc
YHOO
$8.58M 0.15%
+199,070
New +$8.16M
MPC icon
32
CALL
Marathon Petroleum
MPC
$91B
$8.12M 0.14%
200,000
PTHN
33
DELISTED
Patheon N.V.
PTHN
$7.21M 0.13%
+243,271
New +$6.66M
RARE icon
34
Ultragenyx Pharmaceutical
RARE
$2.92B
$5.68M 0.1%
+80,125
New +$5.11M
GWPH
35
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.52M 0.1%
+41,600
New +$3.98M
INCY icon
36
Incyte
INCY
$23.9B
$5.5M 0.1%
+58,385
New +$4.92M
NUVA
37
DELISTED
NuVasive, Inc.
NUVA
$5.38M 0.09%
+80,744
New +$5.14M
SAGE
38
DELISTED
Sage Therapeutics
SAGE
$5.12M 0.09%
+111,127
New +$4.52M
PBYI icon
39
Puma Biotechnology
PBYI
$428M
$5.1M 0.09%
+76,074
New +$3.85M
DERM
40
DELISTED
Dermira, Inc.
DERM
$5.05M 0.09%
+149,457
New +$4.81M
RDUS
41
DELISTED
Radius Health, Inc.
RDUS
$5M 0.09%
+92,394
New +$4.7M
BMRN icon
42
BioMarin Pharmaceuticals
BMRN
$11.6B
$4.89M 0.09%
+52,890
New +$4.98M
NBIX icon
43
Neurocrine Biosciences
NBIX
$17.3B
$4.87M 0.09%
+96,210
New +$4.79M
ACAD icon
44
Acadia Pharmaceuticals
ACAD
$4.4B
$4.75M 0.08%
+149,252
New +$5.06M
KMI icon
45
CALL
Kinder Morgan
KMI
$72.8B
$4.63M 0.08%
+200,000
New +$4.24M
USFD icon
46
US Foods
USFD
$21.8B
$3.6M 0.06%
152,500
-322,500
-68% -$7.83M
TWTR
47
CALL
DELISTED
Twitter, Inc.
TWTR
$2.31M 0.04%
+100,000
New +$1.88M
APFH
48
DELISTED
AdvancePierre Foods Holdings
APFH
$2.06M 0.04%
+74,900
New +$1.88M
SCTY
49
PUT
DELISTED
SolarCity Corporation
SCTY
$1.96M 0.03%
+100,000
New +$2.24M
AN icon
50
AutoNation
AN
$7.01B
-3,044,957
Closed -$143M

Similar funds

Jana Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Jana Partners held 67 positions worth $5.71B, down 2.4% from $5.85B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Jana Partners withdrew a net $332M in Q3 2016, closing 18 positions and reducing 8 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $381M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 21% of assets, down from 23% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, Jana Partners opened a new position in Johnson Controls International worth $260M.

  • Jana Partners's largest Q3 2016 buy was Johnson Controls International: 5,598,283 shares worth $260M.
  • Jana Partners added most to HD Supply Holdings, Inc. in Q3 2016, an estimated $185M increase.
  • Jana Partners's biggest Q3 2016 reduction was Alphabet (Google) Class C, cutting an estimated $241M.
  • Jana Partners fully exited Walgreens Boots Alliance in Q3 2016, selling an estimated $381M.
  • Jana Partners's ten largest holdings make up 65% of its $5.71B portfolio in Q3 2016.
  • Jana Partners opened 30 new positions and closed 18 in Q3 2016.
  • Jana Partners's portfolio value fell 2.4% quarter-over-quarter to $5.71B.

Based on Jana Partners's 13F filing for Q3 2016, filed 14 Nov 2016.